In line with these preclinical observations, it was reported that strong and long-lasting CD4 T cell memory responses of Th1 type, generally associated with antitumor responses, are induced in advanced melanoma patients upon vaccination consisting of the synthetic NY-ESO-1119–143 peptide, Montanide and CpG-ODNs as adjuvants [56]. Here, CD4 is linked to melanoma.